Evidence map›Paper›PMID 33922120›Full record

ArticleVaccines2021

A Novel E2 Glycoprotein Subunit Marker Vaccine Produced in Plant Is Able to Prevent Classical Swine Fever Virus Vertical Transmission after Double Vaccination.

Youngmin Park, Yeonsu Oh, Miaomiao Wang, Llilianne Ganges, José Alejandro Bohórquez, Soohong Park, Sungmin Gu, Jungae Park, Sangmin Lee, Jongkook Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Youngmin ParkBioApplications Inc., Pohang 37668, Korea.ORCID 0000-0003-1174-3793
Yeonsu OhCollege of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon 24341, Korea.ORCID 0000-0001-5743-5396
Miaomiao WangOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, 08193 Barcelona, Spain.
Llilianne GangesOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, 08193 Barcelona, Spain.ORCID 0000-0002-8644-3560
José Alejandro BohórquezOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, 08193 Barcelona, Spain.ORCID 0000-0002-6715-1757
Soohong ParkBioApplications Inc., Pohang 37668, Korea.
Sungmin GuBioApplications Inc., Pohang 37668, Korea.
Jungae ParkBioApplications Inc., Pohang 37668, Korea.
Sangmin LeeBioApplications Inc., Pohang 37668, Korea.
Jongkook KimBioApplications Inc., Pohang 37668, Korea.
Eunju SohnBioApplications Inc., Pohang 37668, Korea.
Kangwon National University · KR

Funding

J.A.B has a pre-doctoral fellowship, FPI 2016, Ministerio de Ciencia e Innovación, from Spanish government FPI 2016M.W. has a pre-doctoral fellowship, CSC scholarship (2017), from the Chinese government. CSC scholarship (2017)
6 · The paper itself

Abstract

The efficacy of a novel subunit vaccine candidate, based in the CSFV E2 glycoprotein produced in plants to prevent classical swine fever virus (CSFV) vertical transmission, was evaluated. A

Indexed as

classical swine fever virusE2 glycoproteinmarker vaccineplantprotectionvertical transmission

Identifiers

PMID33922120
PMCPMC8143534
OpenAlexW3153058491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.